Trillium Therapeutics @6.30Cd
Review SEC Form 13F institutional ownership, reported holding value and quarterly holder changes for Trillium Therapeutics @6.30Cd preferred, CUSIP 89620X100.
Review SEC Form 13F institutional ownership, reported holding value and quarterly holder changes for Trillium Therapeutics @6.30Cd preferred, CUSIP 89620X100.